CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the election of Malcolm MacCoss, Ph.D., FRSC, to the Company's Board of Directors as a class II director. Dr. MacCoss has nearly 30 years of drug discovery and development experience with large international pharmaceutical companies.
